Skip to main content
. 2021 Dec 23;4(3):e177–e187. doi: 10.1016/S2665-9913(21)00394-5

Figure 3.

Figure 3

Adverse events following two or three vaccine doses in patients and controls

(A) All patients. (B) Controls. (C) Patients who received three vaccine doses. Adverse events were reported for all patients and a subset (n=246) of healthy controls (health-care workers at Diakonhjemmet Hospital and Akershus University Hospital, Oslo, Norway). *Duration not measured. †No patients were hospitalised due to disease flares after vaccination.